about
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisA pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityA genome-wide association study in progressive multiple sclerosisMGAT5 alters the severity of multiple sclerosisGenome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients.The burden of multiple sclerosis variants in continental Italians and Sardinians.Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.Uncovering the genetic architecture of multiple sclerosis.Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis.GNAL deletion as a probable cause of dystonia in a patient with the 18p- syndrome.Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansMicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkersProgranulin gene variability increases the risk for primary progressive multiple sclerosis in malesInverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosisMGAT5 and disease severity in progressive multiple sclerosisGenome sequencing uncovers phenocopies in primary progressive multiple sclerosis
P50
Q24635370-BE2DD3C5-217B-44D2-A76E-874CEAC16365Q28261215-5F44EBD3-9E03-4C73-B0E1-D2C6F44D17B5Q28943404-E3DEEDE9-86E3-4CD8-B598-9C79CA2DC5C0Q28943534-12A83AC5-FA79-4FDE-8F1F-DB84BA8124D8Q29417047-54574C03-1BF5-4D59-ABC9-54B5F2A7915BQ33533349-756F2EA5-559D-4AE6-851D-1D3B833BFCD4Q34778605-A418D44B-5312-4A0F-BC59-A775D8D6A51BQ37322100-59AD585B-1456-4C4A-8901-C306DCA94F0BQ40422912-898E7FE7-EAF2-4E2A-AB81-A85340B0C28DQ41096503-90C16803-E655-4B4B-80D1-BD23DEC532D4Q41260237-7E8D7A6B-23D5-41BE-8F3E-658F3E4AC360Q41589802-7C13EAF2-9148-44E2-8AD5-51ACA317FE3EQ43464162-E4B9FD0B-E690-44B4-AC70-6CB37FEA5619Q43643907-1C7CE101-E331-4B40-A2E5-27F1B8A91D60Q43857891-C2BDB858-D29A-45D5-986E-4F0E9A64E03FQ44116778-F03D505B-FE5B-4E56-B48B-F37CF0D01ADDQ45789443-DB16558E-5536-4B81-BD3B-B1DAB6233AEAQ46314403-2A424C55-9656-45F3-9827-D66425946182Q52727172-6BC24B31-137B-4AC7-9E17-258E62B160B7Q52897470-9CA31C7E-D6A7-41E5-B590-DDC0E5824CF4Q53073845-0454E121-BFA2-4046-B153-6B3AA8DB84CCQ59543670-3CAB591D-F977-45CD-8D21-F8325073870BQ59543676-4A0103BB-D6BA-4627-9E43-DFBB57A24F0BQ59543697-A183FBF4-ABB2-4BC9-9C94-59459D7D00C0Q59683405-A7F45E71-F7CC-4D77-A011-4C3594DE1E30Q64042141-9AB9E2D0-DA64-457D-9ED1-EA92FBA936FBQ89122520-2928E6EF-4FD9-4B1B-A976-84BCACB24D30
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Federica Esposito
@ast
Federica Esposito
@en
Federica Esposito
@es
Federica Esposito
@nl
Federica Esposito
@sl
type
label
Federica Esposito
@ast
Federica Esposito
@en
Federica Esposito
@es
Federica Esposito
@nl
Federica Esposito
@sl
prefLabel
Federica Esposito
@ast
Federica Esposito
@en
Federica Esposito
@es
Federica Esposito
@nl
Federica Esposito
@sl
P106
P1153
36058717600
P21
P31
P496
0000-0003-2550-0805